Recent

% | $
Quotes you view appear here for quick access.

Amarin Corporation plc Message Board

  • i832u i832u Oct 5, 2012 4:02 PM Flag

    Week after week this board idiots are so "sure" of so called buyout

    but nothing has happened only huge disappointment is coming.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • You're overlooking several fundamental points. There are no other $B opportunities that Phama
      can go after, and PFE, MRK AZN have had major revenue losses due to patent cliffs. Aside from
      a combo pill (Statin and Vascepa) all of the above would be very motivated to aquire AMRN. This
      can't happen until a proper valuation can be determined, and that can't occur until a decision is
      made on the NCE. I just happen to be in Industry, and can suggest that interest level is high. I am
      not involved with any of the above mentioned companies.

      Sentiment: Strong Buy

    • Reason is BID vs.ASKED
      In April/MAY 2011-- Bid was 15 and ASK was 30---check Bloomberg article on June10,2011.
      Now it is Bid 20$ and Ask is 30$/share.
      Lazard Ltd. has to bridge the gap somehow or find a compromise.

      Example: BMY bid 22$ for Amylin---Amaylin was asking 34$

      BMY upped the bid to 26$--but Amaylin changed ASK to 33$.

      Finally Goldman Sachs found Astra Zeneca to jointly bid with Bristol Myers.
      The bid was raised to 31$/share. Amaylin accepted.
      I owned AMLN--and read the bidding process in SEC report.
      Goldman Sachs played a great role.

      Lazard must be trying to narrow the gap -so Amarin's CEO accepts and can sell it to the Board of Directors and shareholders.

      Sentiment: Buy

 
AMRN
2.39+0.01(+0.42%)Jul 28 4:00 PMEDT